UK markets closed
NIKKEI 225
40,074.69 +443.63 (+1.12%) HANG SENG
17,769.14 +50.53 (+0.29%) CRUDE OIL
83.16 -0.22 (-0.26%) GOLD FUTURES
2,331.20 -7.70 (-0.33%) DOW
39,110.89 -58.63 (-0.15%) Bitcoin GBP
48,752.11 -1,120.95 (-2.25%)
Werewolf Therapeutics, Inc. (HOWL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 12:12PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 102.12M |
| Enterprise value | 14.20M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 5.41 |
| Price/book (mrq) | 0.87 |
| Enterprise value/revenue | 0.88 |
| Enterprise value/EBITDA | 0.57 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.62 |
| 52-week change 3 | -24.92% |
| S&P500 52-week change 3 | 23.12% |
| 52-week high 3 | 8.1940 |
| 52-week low 3 | 1.5740 |
| 50-day moving average 3 | 4.5190 |
| 200-day moving average 3 | 4.2437 |
Share statistics
| Avg vol (3-month) 3 | 298.77k |
| Avg vol (10-day) 3 | 822.47k |
| Shares outstanding 5 | 43.46M |
| Implied shares outstanding 6 | 43.46M |
| Float 8 | 21.73M |
| % held by insiders 1 | 6.27% |
| % held by institutions 1 | 74.42% |
| Shares short (14 Jun 2024) 4 | 487.91k |
| Short ratio (14 Jun 2024) 4 | 2.27 |
| Short % of float (14 Jun 2024) 4 | 1.92% |
| Short % of shares outstanding (14 Jun 2024) 4 | 1.12% |
| Shares short (prior month 15 May 2024) 4 | 372.02k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -256.33% |
| Operating margin (ttm) | -2,312.94% |
Management effectiveness
| Return on assets (ttm) | -15.24% |
| Return on equity (ttm) | -34.84% |
Income statement
| Revenue (ttm) | 16.22M |
| Revenue per share (ttm) | 0.43 |
| Quarterly revenue growth (yoy) | -83.40% |
| Gross profit (ttm) | N/A |
| EBITDA | -43.64M |
| Net income avi to common (ttm) | -41.58M |
| Diluted EPS (ttm) | -1.1000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 139.19M |
| Total cash per share (mrq) | 3.2 |
| Total debt (mrq) | 51.27M |
| Total debt/equity (mrq) | 43.60% |
| Current ratio (mrq) | 6.71 |
| Book value per share (mrq) | 2.72 |
Cash flow statement
| Operating cash flow (ttm) | -38.01M |
| Levered free cash flow (ttm) | -27.25M |
© 2024 Yahoo. All rights reserved.